Kaneka acquires Israeli medtech pioneer
Kaneka Corporation, a Japan-based multinational operating in chemicals and medical technologies, has acquired 96.8% of EndoStream Medical, an Israeli company specialising in innovative medical devices for aneurysm treatment.
The deal, valued at approximately USD 100 million, includes provisions for future sales milestones. EndoStream, based in Or Akiva, is renowned for its Nautilus device, designed for advanced cerebrovascular care.
This acquisition marks the first significant Japanese corporate investment in Israel since October 2023, reflecting a strategic commitment to advancing global healthcare solutions.
Arnon, Tadmor Levy represented Kaneka, with legal counsel provided by Eliran Furman, Peter Sugarman, andEvyatar Katz, supported by Japanese law firm Oh-Ebashi LPC & Partners, while Erdinast, Ben Nathan, Toledani advised EndoStream Medical with legal counsel provided by Yoav Dankner, Oded Natan, Shani Tal Even Zahav, Tal Alon (Tax) and Eyal Birenberg (Labor Law)
